Vectorious reports positive results from VECTOR-HF I study of V-LAP system
NS Medical Devices
The first clinical data of an implantable heart sensor with remote measurement capacity was presented at the prestigious ESC Heart Failure 2022 Late-Breaking Science event
Vectorious’ in-heart microcomputer wins FDA breakthrough nod
Mass Device
FDA Breakthrough Device Designation is granted to devices that have the potential to offer a “more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases.”
"I did not see myself developing another chip sitting in the box, I wanted to develop something with impact"
Calcalist (Hebrew)
Oren Goldshtein, Vectorious CEO, speaks to Navot Volk and Aviv Frenkel, Calcalist – one of Israel’s leading financial news outlets – to discuss the Vectorious story.
